AJP - Regu AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 264: R109-R115, 1993;
0363-6119/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egawa, M.
Right arrow Articles by Bray, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egawa, M.
Right arrow Articles by Bray, G. A.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 264, Issue 1 109-R115, Copyright © 1993 by American Physiological Society

ARTICLES

Effect of beta-endorphin on sympathetic nerve activity to interscapular brown adipose tissue

M. Egawa, H. Yoshimatsu and G. A. Bray
Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

beta-Endorphin was injected into the third cerebroventricle to investigate its effects on sympathetic nerve activity to interscapular brown adipose tissue (IBAT) in rats. Multiunit discharges of sympathetic nerves to IBAT were recorded electrophysiologically in anesthetized rats. The intracerebroventricular injection of beta-endorphin (125, 250, and 500 pmol/rat in 10 microliters) suppressed sympathetic nerve activity in a dose-related fashion (-23.9 +/- 20.4, -38.7 +/- 7.1, and -66.7 +/- 7.6% 30 min after injection) compared with preinjection baseline. N-acetyl-beta-endorphin (250 pmol) had no effect on sympathetic nerve activity to IBAT. The intraperitoneal injection of naloxone (5.0 mg/rat) did not affect sympathetic nerve activity, but preinjection of naloxone inhibited the suppressive effect of intracerebroventricular injection of beta-endorphin (250 pmol). We conclude that the intracerebroventricular administration of beta-endorphin suppressed the sympathetic nerve activity to IBAT through opioid receptors. The results of this experiment are consistent with the hypothesis that beta-endorphin has a reciprocal effect on food intake and the sympathetic nervous system.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Shi, A. D. Strader, S. C. Woods, and R. J. Seeley
Sexually dimorphic responses to fat loss after caloric restriction or surgical lipectomy
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E316 - E326.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. S. Levine, C. M. Kotz, and B. A. Gosnell
Sugars and Fats: The Neurobiology of Preference
J. Nutr., March 1, 2003; 133(3): 831S - 834.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. Inui
Transgenic Approach to the Study of Body Weight Regulation
Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
K. C. Crisanti and J. E. Fewell
Naloxone does not alter the "regulated" decrease in core temperature during hypoxemia in guinea pigs
J Appl Physiol, September 1, 1998; 85(3): 1150 - 1159.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online